These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18296903)
1. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. Essah PA; Nestler JE; Carmina E J Endocrinol Invest; 2008 Jan; 31(1):35-41. PubMed ID: 18296903 [TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome. Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761 [TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Rocha MP; Marcondes JA; Barcellos CR; Hayashida SA; Curi DD; da Fonseca ÂM; Bagnoli VR; Baracat EC Gynecol Endocrinol; 2011 Oct; 27(10):814-9. PubMed ID: 20807166 [TBL] [Abstract][Full Text] [Related]
4. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome. Hernández-Mijares A; Bañuls C; Gómez-Balaguer M; Bergoglio M; Víctor VM; Rocha M Eur J Clin Invest; 2013 Jun; 43(6):549-56. PubMed ID: 23528141 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Legro RS; Kunselman AR; Dunaif A Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204 [TBL] [Abstract][Full Text] [Related]
7. Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study. Ollila MM; Piltonen T; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Morin-Papunen L J Clin Endocrinol Metab; 2016 Feb; 101(2):739-47. PubMed ID: 26652764 [TBL] [Abstract][Full Text] [Related]
8. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Wild RA; Rizzo M; Clifton S; Carmina E Fertil Steril; 2011 Mar; 95(3):1073-9.e1-11. PubMed ID: 21247558 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D levels and lipid profiles in patients with polycystic ovary syndrome. Moieni A; Haghollahi F; Dashtkoohi M; Abiri A; Salari E; Najafi MS; Tajik N BMC Womens Health; 2024 Aug; 24(1):472. PubMed ID: 39192256 [TBL] [Abstract][Full Text] [Related]
10. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome. Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718 [TBL] [Abstract][Full Text] [Related]
11. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Dyslipidaemia and Pre-Diabetes Among Women with Polycystic Ovary Syndrome (PCOS): Do We Overestimate Cardiovascular Risk? Lewandowski KC; Płusajska J; Horzelski W; Lewiński A Horm Metab Res; 2019 Aug; 51(8):539-545. PubMed ID: 31075796 [TBL] [Abstract][Full Text] [Related]
13. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Carmina E; Legro RS; Stamets K; Lowell J; Lobo RA Hum Reprod; 2003 Nov; 18(11):2289-93. PubMed ID: 14585875 [TBL] [Abstract][Full Text] [Related]
14. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome. Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562 [TBL] [Abstract][Full Text] [Related]
15. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial. Abedini M; Ghasemi-Tehrani H; Tarrahi MJ; Amani R Phytother Res; 2021 Jan; 35(1):442-451. PubMed ID: 32767710 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713 [TBL] [Abstract][Full Text] [Related]
17. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993 [TBL] [Abstract][Full Text] [Related]
18. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome. Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907 [TBL] [Abstract][Full Text] [Related]
19. Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. Joharatnam J; Barber TM; Webber L; Conway GS; McCarthy MI; Franks S Clin Endocrinol (Oxf); 2011 Jun; 74(6):714-9. PubMed ID: 21521255 [TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia and oxidative stress in PCOS. Macut D; Bjekić-Macut J; Savić-Radojević A Front Horm Res; 2013; 40():51-63. PubMed ID: 24002405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]